Diagnostic challenge of secondary (metastatic) ovarian tumors simulating primary endometrioid and mucinous neoplasms

Pathology International

Volumn 55, Issue 5, 2005, Pages 231-243

  Hart, William R ^a,b  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Appendix; Colon; Immunohistochemistry; Metastatic carcinoma; Mucinous carcinoma; Ovarian neoplasms; Pancreas; Pseudoendometrioid carcinoma; Pseudomyxoma peritonei

Indexed keywords

CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; GENE PRODUCT; MUCIN;

ALPHA METHYLACYL COENZYME A RACEMASE GENE; APPENDIX ADENOCARCINOMA; APPENDIX TUMOR; BETA CATENIN GENE; CARCINOID; CDX2 GENE; CYSTADENOMA; DIAGNOSTIC ERROR; DIGESTIVE SYSTEM TUMOR; ENDOMETRIOID CARCINOMA; FEMALE; GENE; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE INTESTINE TUMOR; MUCINOUS CARCINOID; MUCINOUS CARCINOMA; OVARY CARCINOMA; OVARY METASTASIS; OVARY TUMOR; PANCREAS ADENOCARCINOMA; PANCREAS TUMOR; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

APPENDICEAL NEOPLASMS; CARCINOMA, ENDOMETRIOID; CYSTADENOMA, MUCINOUS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INTESTINAL NEOPLASMS; INTESTINE, LARGE; OVARIAN NEOPLASMS; OVARY; PANCREATIC NEOPLASMS;

EID: 20444504743     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2005.01819.x     Document Type: Review

References (76)

1. Holtz F, Hart WR. Krukenberg tumors of the ovary: a clinicopathologic analysis of 27 cases. Cancer 1982; 50: 2438-47.
2. Bullon A, Young RH, Arseneau J, Scully RE, Prat J. Tubular Krukenberg tumor: a problem in histopathologic diagnosis. Am J Surg Pathol 1981; 5: 225-32.
3. Santesson L, Kottmeier HL. General classification of ovarian tumors. In: Gentil F, Junqueira AC, eds. Ovarian Cancer (UICC Monograph Series), Vol. 11. New York: Springer-Verlag, 1968; 1-8.
4. Ulbright TM, Roth LM, Stehman FB. Secondary ovarian neoplasm: a clinicopathologic study of 35 cases. Cancer 1984; 53: 1164-74.
5. Yakushiji M, Tazaki T, Nishimura H, Kalo T. Krukenberg tumors of the ovary: a clinicopathologic analysis of 112 cases. Nippon Sanka Fujinka Gakkai Zasshi 1987; 39: 479-85.
6. Yada-Hashimoto N, Yamamoto T, Kamiura S et al. Metastatic ovarian tumors: a review of 64 cases. Gynecol Oncol 2003; 89: 314-17.
7. Demopoulos RI, Touger L, Dublin N. Secondary ovarian carcinoma: a clinical and pathological evaluation. Int J Gynecol Pathol 1987; 6: 166-75.
8. Ayhan A, Tuncer ZS, Bukulmez O. Malignant tumors metastatic to the ovaries. J Surg Oncol 1995; 60: 268-76.
9. Shi Y, Ye D, Lu W, Zhao C, Xu J, Chen L. [Histological classification in 10 288 cases of ovarian malignant tumors in China.] Zhonghua Fu Chan Ke Za Zhi 2002; 37: 97-100 (in Chinese).
10. Gagnon Y, Tetu B. Ovarian metastases of breast carcinoma: a clinicopathologic study of 59 cases. Cancer 1989; 64: 892-8.
11. Fujiwara K, Ohishi Y, Koike H, Sawada S, Moriya T, Kohno I. Clinical implications of metastases to the ovary. Gynecol Oncol 1995; 59: 124-8.
12. Moore RG, Chung M, Granai CO, Gajewski W, Steinhoff MM. Incidence of metastasis to the ovaries from nongenital tract primary tumors. Gynecol Oncol 2004; 93: 87-91.
13. Petru E, Pickel H, Heydarfadai M et al. Nongenital cancers metastatic to the ovary. Gynecol Oncol 1992; 44: 83-6.
14. Yazigi R, Sandstad J. Ovarian involvement in extragenital cancer. Gynecol Oncol 1989; 34: 84-7.
15. Johansson H. Clinical aspects of metastatic ovarian cancer of extragenital origin. Acta Obstet Gynecol Scand 1960; 39: 681-97.
16. Young RH, Carey RW, Robboy SJ. Breast carcinoma masquerading as primary ovarian neoplasm. Cancer 1981; 48: 210-12.
17. Perucchini D, Caduff R, Schar G, Fink D, Kochli OR. Ovarian metastasis of extragenital tumors at the Zurich University Clinic 1978-1990. Geburtshilfe Frauenheilkd 1996; 56: 351-6.
18. Hwa HL, Yen ML, Chen CA, Hsieh CY. Secondary ovarian malignancy of extragenital origin: clinical and analysis of 42 cases. J Formos Med Assoc 1992; 91: 526-30.
19. Liu LY. [Metastatic cancer in the ovary: report of 57 cases.] Zhonghua Zhong Liu Za Zhi 1989; 11: 464-7 (in Chinese).
20. Lee KR, Young RH. The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases. Am J Surg Pathol 2003; 27: 281-92.
21. Lash RH, Hart WR. Intestinal adenocarcinomas metastatic to the ovaries: a clinicopathologic evaluation of 22 cases. Am J Surg Pathol 1987; 11: 114-21.
22. Young RH, Hart WR. Metastatic intestinal carcinomas simulating primary ovarian clear cell carcinoma and secretory endometrioid carcinoma: a clinicopathologic and immunohistochemical study of five cases. Am J Surg Pathol 1998; 22: 805-15.
23. Prayson RA, Hart WR, Petras RE. Pseudomyxoma peritonei: a clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am J Surg Pathol 1994; 18: 591-603.
24. Young R, Gilks B, Scully R. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei: a clinicopathologic analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol 1991; 15: 415-29.
25. Ronnett BM, Kurman RJ, Shmookler BM, Sugarbaker PH, Young RH. The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am J Surg Pathol 1997; 21: 1144-55.
26. Young RH, Hart WR. Metastases from carcinomas of the pancreas simulating primary mucinous tumors of the ovary: a report of seven cases. Am J Surg Pathol 1989; 13: 748-56.
27. Renaud MC, Plante M, Roy M. Metastatic gastrointestinal tract cancer presenting as ovarian carcinoma. J Obstet Gynaecol Can 2003; 25: 819-24.
28. Chang TC, Changchien CC, Tseng CW et al. Retrograde lymphatic spread: a likely route for metastatic ovarian cancers of gastrointestinal origin. Gynecol Oncol 1997; 66: 372-7.
29. Young RH, Scully RE. Metastatic tumors of the ovary. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract, 3rd edn. New York: Springer, 1987; 742-68.
30. Harcourt KF, Dennis DL. Laparotomy for Ovarian tumors' in unsuspected carcinoma of the colon. Cancer 1968; 21: 1244-6.
31. Xu L, Zhan YQ. Clinical analysis of 55 ovarian metastatic tumors from digestive system. Ai Zheng 2002; 21: 311-13.
32. Daya D, Nazerali L, Frank GL. Metastatic ovarian carcinoma of large intestinal origin simulating primary ovarian carcinoma: a clinicopathologic study of 25 cases. Am J Clin Pathol 1992; 97: 751-8.
33. DeCostanzo DC, Elias JM, Chumas JC. Necrosis in 84 ovarian carcinomas: a morphologic study of primary versus metastatic colonic carcinoma with a selective immunohistochemical analysis of cytokeratin subtypes and carcinoembryonic antigen. Int J Gynecol Pathol 1997; 16: 245-9.
34. Misdraji J, Yantiss RK, Graeme-Cook FM, Balis UJ, Young RH. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol 2003; 27: 1089-103.
35. O'Connell JT, Tomlinson JS, Roberts AA, McGonigle KF, Barsky SH. Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells. Am J Pathol 2002; 161: 551-64.
36. Carr NJ, Sobin LH. Unusual tumors of the appendix and pseudomyxoma peritonei. Semin Diagn Pathol 1996; 13: 314-25.
37. Ronnett BM, Kurman RJ, Zahn CM et al. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol 1995; 26: 509-24.
38. Ronnett BM, Van H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 2001; 92: 85-91.
39. O'Connell JT, Hacker CM, Barsky SH. MUC2 is a molecular marker for pseudomyxoma peritonei. Mod Pathol 2002; 15: 958-72.
40. Hart WR, Morris HJ. Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior. Cancer 1973; 31: 1031-45.
41. Lee KR, Scully RE. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'. Am J Surg Pathol 2000; 24: 1447-64.
42. McKenney JK, Soslow RA, Longacre TA. Mucinous neoplasms arising in mature teratomas: a clinicopathologic study of ovarian and sacrococcygeal tumors. Mod Pathol 2004; 17: 206A.
43. Ronnett BM, Seidman JD. Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei. Am J Surg Pathol 2003; 27: 650-57.
44. Baker PM, Oliva E, Young RH, Talerman A, Scully RE. Ovarian mucinous carcinoids including some with a carcinomatous component. Am J Surg Pathol 2001; 25: 557-68.
45. Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. In: Rosai J, ed. Atlas of Tumor Pathology, Third Series, Fascicle 23. Washington DC: Armed Forces Institute of Pathology, 1998; 348-9.
46. Lagendijk JH, Mullink H, van Diest PJ, Meijer GA, Meijer CJ. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Hum Pathol 1998; 29: 491-7.
47. Lagendijk JH, Mullink H, van Diest P, Meijer GA, Meijer CJLM. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. J Clin Pathol 1999; 52: 283-90.
48. Dabbs DJ, Sturtz K, Zaino RJ. The immunohistochemical discrimination of endometrioid adenocarcinomas. Hum Pathol 1996; 27: 172-7.
49. Fleuren GJ, Nap M. Carcinoembryonic antigen in primary and metastatic ovarian tumors. Gynecol Oncol 1988; 30: 407-15.
50. Chou Y-Y, Jeng Y-M, Kao H-L, Chen T-J, Mao T-L, Lin M-C. Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with b-catenin. Histopathology 2003; 43: 151-6.
51. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology 2002; 40: 403-39.
52. Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 1995; 3: 99-107.
53. Wauters CCAP, Smedts F, Gerrits LGM, Bosman FT, Ramaekers FCS. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum Pathol 1995; 26: 852-5.
54. Ji H, Isacson C, Seidman JD, Kurman RJ, Ronnett BM. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Int J Gynecol Pathol 2002; 21: 391-400.
55. Ronnett BM, Shmookler BM, Diener-West M, Sugarbaker PH, Kurman RJ. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol 1997; 16: 1-9.
56. Lee MJ, Lee HS, Kim WH, Choi Y, Yang M. Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol 2003; 16: 403-10.
57. Park SY, Kim HS, Hong EK, Kim WH. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum Pathol 2002; 33: 1078-85.
58. Shishi J, Ghazizadeh M, Oguro T, Aihara K, Araki T. Immunohistochemical localization of CA 125 antigen in formalin fixed paraffin sections of ovarian tumors with the use of Pronase. Am J Clin Pathol 1986; 85: 595-8.
59. Neunteufel W, Breitenecker G. Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: a comparison with CA 19-9 and CEA. Gynecol Oncol 1989; 32: 297-302.
60. Multhaupt HAB, Arenas-Elliott CP, Warhol MJ. Comparison of glycoprotein expression between ovarian and colon adenocarcinomas. Arch Pathol Lab Med 1999; 123: 909-16.
61. Loy TS, Quesenberry JT, Sharp SC. Distribution of CA 125 in adenocarcinomas. An immunohistochemical study of 481 cases. Am J Clin Pathol 1992; 98: 175-9.
62. Goldstein NS, Bassi D, Uzieblo A. WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms. Am J Clin Pathol 2001; 116: 246-52.
63. Albarracin CT, Jafri J, Montag AG, Hart J, Kuan S-F. Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma. Hum Pathol 2000; 31: 672-7.
64. Lau SK, Weiss LM, Chu PG. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites. An immunohistochemical study. Am J Clin Pathol 2004; 122: 61-9.
65. Werling RW, Yaziji H, Bacchi CE, Gown AM. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol 2003; 27: 303-10.
66. Kaimaktchiev V, Terracciano L, Tornillo L et al. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Mod Pathol 2004; 17: 1392-9.
67. Logani S, Oliva E, Arnell PM, Amin MB, Young RH. Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma. Mod Pathol 2005; 18: 19-25.
68. Tornillo L, Moch H, Diener P-A, Lugli A, Singer G. CDX-2 immunostaining in primary and secondary ovarian carcinomas. J Clin Pathol 2004; 57: 641-3.
69. Fraggetta F, Pelosi G, Cafici A, Scollo P, Nuciforo P, Viale G. CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours. Virchows Arch 2003; 443: 782-6.
70. Gaggero G, Sola S, Mora M, Fulcheri E. Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors. Pathologica 2003; 95: 185-91.
71. Groisman GM, Meir A, Sabo E. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries. Int J Gynecol Pathol 2003; 23: 52-7.
72. Gamallo C, Palacios J, Moreno G, de Mora JC, Suarez A, Armas A. b-catenin expression pattern in stage I and II ovarian carcinomas: relationship with b-catenin gene mutations, clinicopathological features, and clinical outcome. Am J Pathol 1999; 155: 527-36.
73. Jiang Z, Fanger GR, Woda BA et al. Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: a study of 761 cases. Hum Pathol 2003; 34: 792-6.
74. Jiang Z, Fanger GR, Banner BF et al. A dietary enzyme: alpha-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma. Cancer Detect Prev 2003; 27: 422-6.
75. Hart W. Mucinous tumors of the ovary: a review. Int J Gynecol Pathol 2005; 24: 4-25.
76. Seidman JD, Kurman RJ, Ronnett BM. Primary and metastatic mucinous adenocarcinoma of the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol 2003; 27: 985-93.